ID

39635

Beschrijving

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1); ODM derived from: https://clinicaltrials.gov/show/NCT01963611

Link

https://clinicaltrials.gov/show/NCT01963611

Trefwoorden

Versies (2)
  1. 19-01-19 19-01-19 -
  2. 06-02-20 06-02-20 - Christian Arras
Houder van rechten

EMD Serono

Geüploaded op

6 februari 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Relapsing Remitting Multiple Sclerosis NCT01963611

Engels

Eligibility Relapsing Remitting Multiple Sclerosis NCT01963611

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, between the ages of 18 and 60 years
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
subject is able to learn and self-administer subcutaneous injections or a care-giver may be trained to inject the subject
Beschrijving

Subcutaneous injections, self-administration, ability | administration procedure, caregiver

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021499
UMLS CUI [1,2]
C0036589
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0021499
UMLS CUI [2,2]
C1533734
UMLS CUI [2,3]
C0085537
subjects must have a current diagnosis of relapsing remitting multiple sclerosis (rrms) (according to the 2010 mcdonald ms diagnostic criteria)
Beschrijving

Diagnosis of RRMS

Datatype

boolean

Alias
UMLS CUI [1,1]
C0751967
UMLS CUI [1,2]
C0679228
other protocol defined inclusion criteria could apply
Beschrijving

Inclusion criteria, Study protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348563
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
any multiple sclerosis categorized as primary progressive, secondary progressive or progressive relapsing
Beschrijving

Multiple Sclerosis Primary Progressive, Multiple Sclerosis Secondary Progressive, Multiple Sclerosis Progressive Relapsing

Datatype

boolean

Alias
UMLS CUI [1]
C0751964
UMLS CUI [2]
C0751965
UMLS CUI [3]
C0393666
allergy to mannitol, plovamer acetate, copaxone (glatiramer acetate), gd contrast for mri
Beschrijving

Hypersensitivity, Mannitol, Plovamer acetate, Copaxone, Gadolinium

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0024730
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C3272845
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0528175
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0016911
any requirement for continuous systemic glucocorticoid administration during the trial period.
Beschrijving

note: treatment with interferons such as avonex®, rebif®, or betaseron® will be allowed until the baseline visit, as no wash-out period is needed

Datatype

boolean

Alias
UMLS CUI [1,1]
C0744425
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C2347804
contraindication to copaxone use
Beschrijving

Contraindiction Copaxone

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0528175
other protocol defined exclusion criteria could apply
Beschrijving

Exclusion criteria

Datatype

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348563
Terug naar het begin van de pagina

Similar models

Eligibility Relapsing Remitting Multiple Sclerosis NCT01963611

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Gender, Age
Item
male or female, between the ages of 18 and 60 years
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Subcutaneous injections, self-administration, ability | administration procedure, caregiver
Item
subject is able to learn and self-administer subcutaneous injections or a care-giver may be trained to inject the subject
boolean
C0021499 (UMLS CUI [1,1])
C0036589 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0021499 (UMLS CUI [2,1])
C1533734 (UMLS CUI [2,2])
C0085537 (UMLS CUI [2,3])
Relapsing remitting multiple sclerosis, current diagnosis, McDonald diagnostic criteria
Item
subjects must have a current diagnosis of relapsing remitting multiple sclerosis (rrms) (according to the 2010 mcdonald ms diagnostic criteria)
boolean
C0751967 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
Inclusion criteria, Study protocol
Item
other protocol defined inclusion criteria could apply
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Multiple Sclerosis Primary Progressive, Multiple Sclerosis Secondary Progressive, Multiple Sclerosis Progressive Relapsing
Item
any multiple sclerosis categorized as primary progressive, secondary progressive or progressive relapsing
boolean
C0751964 (UMLS CUI [1])
C0751965 (UMLS CUI [2])
C0393666 (UMLS CUI [3])
Hypersensitivity, Mannitol, Plovamer acetate, Copaxone, Gadolinium
Item
allergy to mannitol, plovamer acetate, copaxone (glatiramer acetate), gd contrast for mri
boolean
C0020517 (UMLS CUI [1,1])
C0024730 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C3272845 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0528175 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0016911 (UMLS CUI [4,2])
Glucocorticoid therapy, Clinical trial period
Item
any requirement for continuous systemic glucocorticoid administration during the trial period.
boolean
C0744425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
Contraindiction Copaxone
Item
contraindication to copaxone use
boolean
C1301624 (UMLS CUI [1,1])
C0528175 (UMLS CUI [1,2])
Exclusion criteria
Item
other protocol defined exclusion criteria could apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial